Skip to main content
Clinical Trials/NCT00615394
NCT00615394
Completed
Phase 1

Autologous Transplantation of Bone Marrow Mononuclear Stem-Cells by Mini-Thoracotomy in Dilated Cardiomyopathy - Technique and Early Results

Instituto de Cardiologia do Rio Grande do Sul1 site in 1 country6 target enrollmentApril 2004

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Dilated Cardiomyopathy
Sponsor
Instituto de Cardiologia do Rio Grande do Sul
Enrollment
6
Locations
1
Primary Endpoint
safety: morbidity/mortality
Status
Completed
Last Updated
18 years ago

Overview

Brief Summary

Bone marrow mononuclear cells (BMMC) transplantation is a promising therapy for treating ischemic disease, however the effect in non-ischemic dilated cardiomyopathy is unknown.This study describes a technique of BMMC transplantation utilizing mini-thoracotomy and results up to one year after the procedure.

Registry
clinicaltrials.gov
Start Date
April 2004
End Date
December 2006
Last Updated
18 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Instituto de Cardiologia do Rio Grande do Sul

Eligibility Criteria

Inclusion Criteria

  • diagnosis made at more than two years and symptomatic at functional class III-IV by the New York Heart Association classification (NYHA) despite optimal pharmacologic therapy
  • left ventricular ejection fraction (LVEF) less than 35%, by echocardiogram
  • age below 60 years
  • absence of neoplasm
  • absence of hematologic disease or systemic disease
  • no previous cardiac intervention

Exclusion Criteria

  • episodes of tachycardia or ventricular fibrillation
  • severe or moderated mitral insufficiency
  • any other valvulopathies

Outcomes

Primary Outcomes

safety: morbidity/mortality

Time Frame: eighteen months

Study Sites (1)

Loading locations...

Similar Trials